Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a ...
We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...
Stock analysts at Cantor Fitzgerald dropped their FY2024 earnings per share estimates for Maplebear in a research note issued on Tuesday, January 7th. Cantor Fitzgerald analyst D. Mathivanan now ...
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Cantor Fitzgerald assumed coverage on shares of Varonis Systems (NASDAQ:VRNS – Free Report) in a research report sent to investors on Thursday morning, Marketbeat.com reports. The firm issued an ...
Cantor Fitzgerald initiated coverage of Bright Minds Biosciences (DRUG) with an Overweight rating and no price target The company’s emerging ...
Cantor Fitzgerald initiated coverage of Varonis (VRNS) with an Overweight rating and $60 price target The firm believes data security is ...
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering ...
Cambridge Nutritional Sciences PLC has announced that Cantor Fitzgerald Europe has crossed the 5% threshold in its voting rights, now holding 5.207% of the total voting rights. This acquisition of ...